Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tuoli Xiaodu San is a traditional Chinese medicine (TCM) formula traditionally used to promote wound healing and treat chronic inflammatory conditions such as sores, ulcers, and abscesses. The formula is composed of multiple herbal ingredients, typically including *Astragalus membranaceus*, *Angelica sinensis*, *Paeonia lactiflora*, *Atractylodes macrocephala*, *Poria cocos*, *Panax ginseng*, *Lonicera japonica*, *Angelica dahurica*, *Gleditsia sinensis*, *Platycodon grandiflorus*, *Ligusticum chuanxiong*, and *Glycyrrhiza uralensis*. Its mechanism of action involves tonifying Qi and blood, clearing heat, and detoxifying, which collectively enhance local blood circulation, modulate the immune response, and stimulate the formation of granulation tissue. In clinical practice, it is specifically investigated for its efficacy in accelerating wound recovery following surgical procedures for anal fistulas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tuoli Xiaodu San.